Skip to main content Help with accessibility Skip to main navigation

July 2023 updates to the website

The website has now been updated following July's LSCMMG

The following guidelines have been added/updated:

Nutritional Supplements Post Bariatric Surgery

Algorithm For Antihyperglycaemic Therapy in Adults with Type 2 Diabetes

Lipid Management Guidance for Secondary Prevention of CVD


The following Items will be updated following the next ICB approval meeting:

NICE TA 902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

NICE TA 905 Upadacitinib for previously treated moderately to severely active Crohn’s disease

NICE TA 907 Deucravacitinib for treating moderate to severe plaque psoriasis